Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Michon

Showing results (231-240 of 256) with videos related to

Pageof 26
Sort By:
Medical and Pediatric Oncology|July 24, 2001
Intratumoural heterogeneity of 1p deletions and MYCN amplification in neuroblastomasP F Ambros, I M Ambros, R Kerbl, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|July 6, 2004
[Neonatal localized neuroblastoma: 52 cases treated from 1990 to 1999]M B Michalowski, H Rubie, J Michon, et al.
Bone Marrow Transplantation|July 12, 2005
Cost effectiveness of day 5 G-CSF (Lenograstim) administration after PBSC transplantation: results of a SFGM-TC randomised trialD Valteau-Couanet, C Faucher, A Aupérin, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Loss of chromosome 1p may have a prognostic value in localised neuroblastoma: results of the French NBL 90 Study. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP)H Rubie, O Delattre, O Hartmann, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|July 27, 2000
[Opsoclonus-myoclonus syndrome associated with non-metastatic neuroblastoma. Long-term survival. Study of the French Society of Pediatric Oncologists]D Plantaz, J Michon, D Valteau-Couanet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
LMCE3 treatment strategy: results in 99 consecutively diagnosed stage 4 neuroblastomas in children older than 1 year at diagnosisD Frappaz, J Michon, C Coze, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor RegistryR Ladenstein, T Philip, C Lasset, et al.
British Journal of Cancer|November 8, 2006
Incidence and prognostic value of tumour cells detected by RT-PCR in peripheral blood stem cell collections from patients with Ewing tumourJ Vermeulen, S Ballet, O Oberlin, et al.
Annals of Internal Medicine|April 15, 1997
Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. A randomized, controlled trialO Hartmann, A G Le Corroller, D Blaise, et al.
The Journal of Pathology|December 8, 2006
hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entitiesF Bourdeaut, P Fréneaux, B Thuille, et al.
Pageof 26

Showing results (231-240 of 256) with videos related to

Sort By:
Pageof 26
Medical and Pediatric Oncology|July 24, 2001
Intratumoural heterogeneity of 1p deletions and MYCN amplification in neuroblastomasP F Ambros, I M Ambros, R Kerbl, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|July 6, 2004
[Neonatal localized neuroblastoma: 52 cases treated from 1990 to 1999]M B Michalowski, H Rubie, J Michon, et al.
Bone Marrow Transplantation|July 12, 2005
Cost effectiveness of day 5 G-CSF (Lenograstim) administration after PBSC transplantation: results of a SFGM-TC randomised trialD Valteau-Couanet, C Faucher, A Aupérin, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Loss of chromosome 1p may have a prognostic value in localised neuroblastoma: results of the French NBL 90 Study. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP)H Rubie, O Delattre, O Hartmann, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|July 27, 2000
[Opsoclonus-myoclonus syndrome associated with non-metastatic neuroblastoma. Long-term survival. Study of the French Society of Pediatric Oncologists]D Plantaz, J Michon, D Valteau-Couanet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
LMCE3 treatment strategy: results in 99 consecutively diagnosed stage 4 neuroblastomas in children older than 1 year at diagnosisD Frappaz, J Michon, C Coze, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor RegistryR Ladenstein, T Philip, C Lasset, et al.
British Journal of Cancer|November 8, 2006
Incidence and prognostic value of tumour cells detected by RT-PCR in peripheral blood stem cell collections from patients with Ewing tumourJ Vermeulen, S Ballet, O Oberlin, et al.
Annals of Internal Medicine|April 15, 1997
Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. A randomized, controlled trialO Hartmann, A G Le Corroller, D Blaise, et al.
The Journal of Pathology|December 8, 2006
hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entitiesF Bourdeaut, P Fréneaux, B Thuille, et al.
Pageof 26